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Abstract
DREAM is an initiative that allows researchers to assess how well their methods or approaches can describe and predict
networks of interacting molecules [1]. Each year, recently acquired datasets are released to predictors ahead of publication.
Researchers typically have about three months to predict the masked data or network of interactions, using any predictive
method. Predictions are assessed prior to an annual conference where the best predictions are unveiled and discussed. Here
we present the strategy we used to make a winning prediction for the DREAM3 phosphoproteomics challenge. We used
Amelia II, a multiple imputation software method developed by Gary King, James Honaker and Matthew Blackwell[2] in the
context of social sciences to predict the 476 out of 4624 measurements that had been masked for the challenge. To chose
the best possible multiple imputation parameters to apply for the challenge, we evaluated how transforming the data and
varying the imputation parameters affected the ability to predict additionally masked data. We discuss the accuracy of our
findings and show that multiple imputations applied to this dataset is a powerful method to accurately estimate the missing
data. We postulate that multiple imputations methods might become an integral part of experimental design as a mean to
achieve cost savings in experimental design or to increase the quantity of samples that could be handled for a given cost.
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Introduction
DREAM is an initiative that is quite essential in the field of
methods development to critically evaluate current computational
methodologies (http://wiki.c2b2.columbia.edu/dream/index.php/
The_DREAM_Project). In this respect, it follows the well-
established Critical Assessment of methods of protein Structure
Prediction (CASP) [3,4,5,6,7,8], which has spurred innovation in
this field. DREAM is now at its 4
th instance, and there is no doubt
that it will become as beneficial for the Systems Biology world as
CASP already is for the structural biology domain. We participated
in the 3
rd instance of the DREAM challenge, in the phosphopro-
teomics section. Briefly, this challenge is based on a data set
provided by Peter Sorger et al[9], where the authors measured the
difference in signaling between normal and cancerous cells using
phosphoproteomics assays. Predictors were given only 90% of the
data and had to predict the value of the remaining measurements,
which had been masked by the authors. This consisted in predicting
the concentration of 17 phosphoproteins at two time points
for 7 combinations of stimuli and inhibitors applied to normal
and cancer hepatocytes (Figure 1). For each of the 17
phosphoproteins, 42 distinct combinations of stimuli and inhibitors
measurements were given, in addition to un-stimulated and un-
inhibited controls.
In this article, we describe the approach we took to analyze the
data and make a winning prediction, and discuss the applicability
of the process to other data sets. Given the complexity of the
biological networks affected by the various stimuli and inhibitors,
we decided to approach this challenge by imputing the missing
data based solely on the exiting measured data. We took
advantage of the Vital-IT high-performance computing center to
run thousands of simulations to determine the best multiple
imputation parameters to apply for our final prediction. This
article will describe our approach in details. It is important to
mention that, although our multiple imputations strategy resulted
in a winning contribution, it does not provide any insights into the
biomolecular system underlying the data. In other words, it does
not infer nor uses the wiring structure of the signaling network. As
a consequence, it would not be possible to infer the outcome of
multiple simultaneous perturbations on the phosphoproteomics
measurements using this approach. To this end, other methods
that implicitly take advantage of the signaling network using
kinetic modeling or logical modeling should be used [10]. These
methods will likely be used in the 2009 DREAM challenges, as
several groups are focusing their attention towards methodologies
to infer and reconstruct regulatory networks and evaluate their
dynamical behaviour.
Analysis
One interesting aspect of the DREAM challenge is that there is
only about three months between the time the data are released
and the due date for the analysis. This does not leave much time to
develop and validate novel methods, and predictors typically apply
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We took a slightly different approach, which consisted in analyzing
the problem, identifying a suitable tool to perform the analysis,
tuning the parameters during the time allowed and performing our
final prediction. The summary of the analysis workflow is
described in Figure 2. Each step is described in more depth in
the following sections.
Step 1: Understanding the Challenge
We immediately recognized that the masked data could be
assimilated to missing data. Missing data is a recurrent and very
annoying problem, as most statistical tools do not tolerate missing
data. Common ways to deal with this issue include ignoring samples
as soon as one measurement is missing, which prunes the dataset.
Although applicable in cases of large datasets with few missing
values, this is far from ideal and inapplicable in our case, as it is
indeed the objective of the challenge to predict the masked data.
The other common approach is to replace the missing data either
with random values, or by the mean or median of non-missing
values. Both approaches can lead to biases and inefficiencies.
Fortunately, solutions to impute the missing data have been
developed, in particular in the field of social sciences, where
multiple questions polls are usually only partially filled and where
removing any sample partially filled would amount to discarding
most of the dataset. We elected to use the Amelia II package[2] of
R[11], a multiple imputation method described in depth in a report
entitled ‘‘What to do About Missing Values in Time Series Cross-
Section Data’’, available at http://gking.harvard.edu/amelia/.
Step 2: Performing Exploratory Data Analysis
To get a ‘‘feel’’ for the data, we performed a principal
component analysis (PCA) using the dudi.pca module of the ade4
package[12] of R (Figure 3). It is obviously apparent that there is
a large difference between Cancer and Normal cells. Likewise,
some grouping is also apparent for the various time points.
Measurements at time zero and 180mn cluster in relatively tight
neighboring regions of the PCA space. In contrast, there is a large
dispersion of the measurements for time 30 mn. Moreover, those
measurements tend to be further away from measurements at time
zero than measurements at time 180 mn are. Those observations
led us to try various parameters that would account for time effect
and cell type effect (cross-section Normal vs Cancer) during the
multiple imputation process.
Step 3: Optimizing the Multiple Imputation Parameters
Although any additional prior data already present in the
literature could be used to help solve the challenge, we decided to
use only the rich dataset at our disposition to make our
predictions, since the conditions, laboratories and experimentalists
affect experimental readouts. Therefore we committed to two
principles before starting the analysis: (1) let the data drive the
prediction process and (2) do not correct our predictions based on
any particular biological knowledge. Amelia II has several input
parameters, and can apply various transformations to the input
data. To determine the best combination of parameters to use to
impute the missing data of the challenge dataset, we randomly
chose three Stimuli/Inhibitors pairs among the 42 combinations of
Stimuli/Inhibitors for which we had data, with the restriction that
a given Stimulus or Inhibitor could not be picked more than once.
We then masked the 17 phosphoproteomics measurement data
associated with those three pairs at time points 30 and 180 mn for
Cancer and Normal cells. This corresponded to the masking of
204 (17636262) measurements. We then used Amelia II to
impute the 204 masked data with various input parameters and
Figure 1. Description of the DREAM3 phosphoproteomics challenge. 17 phosphoproteins have been measured in Normal and Cancer Cells,
following various combinations of Stimulus and Inhibitor at various time-points. A series of measurements (476 out of 4624) have been masked
(diagonal). The challenge consisted in providing the most accurate prediction of those missing data.
doi:10.1371/journal.pone.0008012.g001
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Pearson correlation coefficient between the median of multiple
imputations and the actual measurement (Figure 4). The process
was repeated 50 times, selecting different combinations of masked
Stimulus/Inhibitors pairs. Thus, we collected 50 correlation
coefficients for any set of multiple imputations parameters tested.
To make our prediction for the challenge, we chose the set of
parameters for which the median of the 50 Pearson Correlation
coefficients was the highest. We then applied those parameters to
the 476 masked data of the challenge.
As can be seen in Figures S1 and S2, the variation of the
multiple imputations parameters influenced the ability to predict
the masked data. In particular, increasing the number of multiple
imputations improved the correlation (Figure S1). Likewise,
increasing the polynomial order used to model the time effect was
beneficial (vectors are parallels in the PCA space; Figure S2).
Actually, we determined that the best correlation was achieved
using a second order polynomial (data not shown). This is
consistent with the observation that time points zero and 180 mn
were close in the PCA space, whereas measurements belonging to
the 30 mn time point were more distant and scattered (Figure 3).
We also observed that when the cell status (Cancer, Normal) was
considered as a cross-section, it was absolutely necessary to allow
modeling of the time effect differently for each cell type. On
another hand, the method used to initialize the imputation process
(listwise deletion or identity matrix) had no effect. The best overall
correlation (0.94) was obtained with 50 multiple imputations, a
cross-section on the cell type and the possibility to apply a different
model of the time effect for each cell type using a second order
polynomial on the raw (untransformed) data.
Discussion
When the number of imputations was large, we did not observe
a statistical difference between imputing the missing data using
untransformed or squared root transformed measurements,
although we noticed a slightly tighter variance when untrans-
formed data was used. Log transforming the data consistently gave
inferior results (data not shown). However, we anticipated a
beneficial effect of transforming the data, because during our
initial data exploration phase, we observed that the measurements
acquired for several of the 17 phosphoproteins were not normally
distributed (data not shown). This violated the assumption made
by the imputation model implemented in Amelia II, which
optimally requires multivariate normally distributed data. During
our search for optimal parameters, we either used the data as-is, or
applied a squared root transformation on all measurements. As the
various phosphoprotein measurements follow distinct distribu-
tions, we reasoned that the putative improvement obtained by
transforming some measurements was compensated by the
detrimental effect of transforming measurements that should have
been left untransformed. Thus, we kept the multiple imputation
parameters that gave us the best correlation with our own masked
data and further evaluated the effect of transforming measure-
ments for just some of the 17 phosphoproteins. We identified that
a squared root transformation of Akt, IkBa, p38, p70S6 and
HSP27 measurements modestly but significantly improved the
overall correlation from 0.94 to 0.95 (unpaired t-test P-value 0.02).
This is what we used for our final prediction.
Overall, the median of the multiple imputation process
produced an extremely accurate estimation of the actual measured
data. Representative predictions examples are provided in
Figure 5. The jury evaluated the predictions using a normalized
square error by comparing the predictions with a null-model in
which the missing values were sampled from the dataset to
estimate a p-value. In our case, the chance to obtain such a
prediction randomly was of 10
222. The main advantage of using
multiple imputations is that it naturally gives a prediction range for
each missing value. We observed that the actual measurement fell
out of this range for only 30 out of the 476 predictions, that is
6.3% of the time (Table S1). Interestingly, 14 of those ‘‘outliers’’
concern the combination of IL-1 stimulation with PI3K inhibition,
and 10 (e.g. a third) are more specifically under-predicted for this
specific combination of stimulus/inhibitor at 30 mn in cancer
cells. The fact that a third of the ‘‘outliers’’ are found in this
combination (out of the 28 distinct combinations of Stimulus/
Inhibitor/CellType/Time for which the data had been masked)
might reflect that PI3K inhibition can affect the apparent
concentration of the IL-1 stimuli perceived by the cell. Indeed
PI3K is linked in part with the rapid induction of IL-1R1[13]. The
combination of TGFa stimulation with GSK3 inhibition also takes
its share of outliers (4 out of 30), and there is evidence that both
play an antagonizing role in the case of keratinocyte migration in
HaCat cells, a cell type similar to the HepG2 cells used to produce
the challenge data[14].
Figure 2. Analysis workflow summary. Description of the different
steps applied to the DREAM challenge.
doi:10.1371/journal.pone.0008012.g002
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irrespective of the CellType, Time, Stimulus and Inhibitor. Scatter plots with representation of the various classes were produced with the s.class
command of the ade4 R package. The various classes are: Top left: CellType (Normal, Cancer). Top right: Time (0, 30, 180 mn). Bottom left: The seven
stimuli. Bottom right: The seven inhibitors.
doi:10.1371/journal.pone.0008012.g003
Figure 4. Identification of the best multiple imputation parameters. A. Selection of three Stimulus/Inhibitor pairs and masking (red) of the
17 associated phosphoproteomics measurements at 30 and 180 mn in both normal and cancer cells (17636262=204 masked measurements). B.
Example of multiple imputations results with a given set of Amelia II parameters for the 17 masked phosphoproteomics measurements associated
with an IFNc stimulation and JNK inhibition at 30 mn in cancer cells. The boxplots show the spread of the 14 multiple imputations performed for
each phophoprotein and the median of the prediction (black) can be compared to the actual measurement (red). C. The correlation between the
median of each of the 204 predictions and the 204 actual measureents which have been masked is computed and provides an evaluation of the
prediction performance for a given set of Amelia II input parameters.
doi:10.1371/journal.pone.0008012.g004
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differently from the other stimuli in our preliminary PCA
(Figure 2). Based on this observation, it was expected that it
would be more challenging to accurately predict the missing values
for those stimuli. To come with a more sensible prediction of IL-1,
it might have been useful to benefit from results of other
interleukin stimuli such as IL-8 or IL-6 to better cover the
signaling space. The PCA (Figure 2) does not discriminate the
various inhibitors, which appear superposed. This is consistent
with the presence of biological cross-talks between those inhibitors,
such as for example GSK3i and PI3Ki[15].
For the DREAM3 challenge, about 10.3% of the measurements
had been masked. Once all of the actual measurements were made
available, we masked 952 out of 4624 measurements (e.g. about
20.6% of the data) randomly drawn from time points other than
zero. We then used the optimal prediction parameters determined
earlier to predict the masked data. Here again, we observed that
the multiple imputation process defined a range in which the
actual measurement almost always fell. Indeed, the actual
measurement fell out of this range for only 49 out of the 952
predictions, that is 5.1% of the time (Table S2). This time, no
clear pattern of misprediction could be identified for the 49
‘‘outliers’’. This absence of clear pattern might be due to the fact
that the masked data was missing completely at random in this
case, which is the best situation for multiple imputations.
After the DREAM conference, out of curiosity, we also tested
the multiple imputation method on another challenge dataset: The
gene expression prediction challenge, whose dataset was gener-
ously provided by Neil Clarke et al. Briefly, the challenge consisted
in predicting the expression level of 50 genes in a gat1D yeast
strain, for different time points following the addition of an
histidine synthesis inhibitor. The expression level of these 50 genes
as well as 9285 others was provided for wild type and 3 other
mutant strains. We first back transformed the data to obtain raw
measurements from the log transformed data supplied, and
formatted the data to place genes in rows and mutants in columns.
Contrarily to the phosphoproteomics challenge, we did not
attempt to identify the optimal multiple imputations parameters
by predicting the measurements of additionally masked genes. We
directly imputed the missing data using just one set of (arbitrary)
parameters: cross-section on the various genes, modeling the effect
of time with a 2
nd order polynomial not varying across the cross-
section, and 100 multiple imputations. We then evaluated what
would have been our performance using the evaluation scripts
used by the assessors, which are available from http://wiki.c2b2.
columbia.edu/dream/index.php/D3c3. Although the prediction
might probably have been improved by careful tuning of the
parameters, it turns out that with this simple protocol, we would
already have achieved the 3
rd best prediction (Table S3), with a
score significantly better than several other predictors. Unfortu-
nately, we cannot comment on the merit and pitfalls of the various
methods used by the participating teams, because only anonymous
rankings are provided by the organizers, so as to encourage
submissions of experimental methods. However, a thorough
comparative study of the different submissions is under prepara-
tion: Robert J. Prill, Daniel Marbach, Julio Saez-Rodriguez,
Gregoire Altan-Bonnet, Peter Sorger, Neil Clarke, Gustavo
Stolovitzky, Lessons from the DREAM3 challenges (this title
may change), DREAM3 collection, PLoS One (to be published).
From this work, we conclude that the multiple imputation
method is a powerful technique that can be generally applied to
many situations relevant to large-scale biological data acquisition
where missing data are encountered, such as microarrays
experiments [16]. This is also particularly relevant to longitudinal
studies where patients might not come to every appointment, or
where measurements might be missing for a variety of reasons. For
example, in a longitudinal study examining 13 biomarkers as
predictors of mortality, about 40% of the participants were missing
information on one or more biomarker [17]. Although we applied
multiple imputations to somewhat artificial conditions where
known data are removed from a set, this work could be extended
to influence the experimental design phase of new projects.
Indeed, most of the current approaches rely on the use of
checkerbox design (combinations of stimuli and inhibitor), which is
very expensive both in time and in consumable price. Knowing
that, for some datasets, as much as 20% of the data could be
imputed could be used to reduce the amount of data to actually
measure to reach a biological conclusion. This approach could
also be used to plan a multi-step experiment approach in which
the best combinations of stimuli and inhibitors worth measuring in
the next experiment are ‘‘imputed’’ from the current experiment,
reminiscent to the ‘‘pay as you go’’ strategy suggested for example
in the protein-protein interactions field[18]. An other potential
application could be to circumvent inherent limitations of some
technologies. For example, flow cytometry cannot simultaneously
quantify more than 10 cell surface markers. This is due to the
difficulty to find fluorescently labeled antibodies whose emission
spectra does not overlap, or to the lack of antibodies coupled to
different fluorophores. It might be possible to design experiments
Figure 5. Evaluation of the quality of the DREAM3 challenge
prediction. The multiple imputation process generated 50 predictions
for each measurement, which are represented as boxplots. The median
(black) was submitted as our prediction. In red, actual experimental
measurement unveiled shortly before the DREAM3 conference. Top:
example of high quality prediction. Bottom: Worse prediction.
doi:10.1371/journal.pone.0008012.g005
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set of antibodies. For example, assuming that antibodies A and D
cannot be used simultaneously, an experiment splitting cells into a
first batch marked with antibodies A,B and C and a second batch
marked with antibodies B,C and D, should make it possible to
impute the missing measurements and thus obtain a prediction of
markers A,B,C and D for each cell.
To conclude, we believe that initiatives such as DREAM and
ENFIN[19], which both provide a framework where the predictive
power of computational methods can be rigorously benchmarked
against experimental data should be encouraged. The structural
biology community benefited strongly from CASP, and the
systems biology and reverse-engineering fields will without doubt
benefit from such initiatives.
Supporting Information
Figure S1 Overall effect of varying the multiple imputation
parameters. The process presented in Figure 4 has been repeated
50 times, masking different selections of 3 pairs of Stimuli/
Inhibitors. In each case, 32 distinct combinations of parameters
were tested, with 18 distinct number of multiple imputations (1–
10, 15, 20, 25, 30, 35, 40, 45 and 50). For each of those 576
(32x18) parameters (x axis), the distribution of the 50 correlations
computed as described in Figure 4C is presented as a boxplot. It is
immediately apparent that for any of the 32 combinations of
parameters tested, increasing the number of multiple imputations
improves the prediction accurracy, but reaches a plateau after
about 40 multiple imputations.
Found at: doi:10.1371/journal.pone.0008012.s001 (0.14 MB
DOC)
Figure S2 Principal Component Analysis of the multiple
imputation parameters effect. #imputations: number of multiple
imputations. Sqrt: Effect of applying a squared root transformation
on all input data. Polytime: Effect of increasing the polynome
order used to model the effect of time. Cross-section: indicates
whether we should consider the cell status (Cancer, Normal) as a
cross-section. Model cross-section time indicates whether the effect
of the time should be modeled differently for Cancer and Normal
cells.
Found at: doi:10.1371/journal.pone.0008012.s002 (0.06 MB
DOC)
Table S1 List of the 30 combinations of Stimulus/Inhibition/
timepoint/CellType measurements (out of 476) whose actual value
falls outside of the min-max prediction range defined by the
multiple imputation process.
Found at: doi:10.1371/journal.pone.0008012.s003 (0.09 MB
DOC)
Table S2 List of the 49 combinations of Stimulus/Inhibition/
timepoint/CellType measurements (out of 952 measurements
masked completely at random) whose actual value falls outside of
the min-max prediction range defined by the multiple imputations
process.
Found at: doi:10.1371/journal.pone.0008012.s004 (0.13 MB
DOC)
Table S3 Assessment of how the multiple imputation method
would have performed on the DREAM3 Expression Challenge.
Score: log-transformed ‘‘average’’ of the overall gene-profile p-
value and the overall time-profile P-value, computed as -0.5 log10
(GeneProfile*TimeProfile); larger scores indicate greater statistical
significance of the prediction. Overall Gene-Profile P-value:
geometric mean of the 50 gene-profile P-values for a given time
point. Overall Time-Profile P-value: geometric mean of the 8
time-profile p-values for a given gene. Assessment details can be
found on the DREAM website at http://wiki.c2b2.columbia.edu/
dream/results/DREAM3/?c=3_1
Found at: doi:10.1371/journal.pone.0008012.s005 (0.04 MB
DOC)
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